{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T21:16:13Z","timestamp":1786828573426,"version":"build-2736575974"},"reference-count":160,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110\/Z\/15\/Z"],"award-info":[{"award-number":["110110\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00004\/03"],"award-info":[{"award-number":["MC_UU_00004\/03"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jhepr.2023.100777","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:16:07Z","timestamp":1682338567000},"page":"100777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":false,"given":"Philippa C.","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-1055","authenticated-orcid":false,"given":"Ponsiano","family":"Ocama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-4145","authenticated-orcid":false,"given":"Anna","family":"Turkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Torimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Garcia Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-8379","authenticated-orcid":false,"given":"Ang\u00e9lica","family":"Espinosa Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-7935","authenticated-orcid":false,"given":"Fernando Pio","family":"De La Hoz Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-2464","authenticated-orcid":false,"given":"Emmanuel","family":"Seremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson","family":"Mbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin Q.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-6930","authenticated-orcid":false,"given":"Homie","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dusheiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Wendy","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-6885","authenticated-orcid":false,"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100777_bib1","series-title":"Towards Ending Viral Hepat. Global health sector strategy on viral hepatitis 2016\u20132021","year":"2016"},{"key":"10.1016\/j.jhepr.2023.100777_bib2","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","year":"2022"},{"key":"10.1016\/j.jhepr.2023.100777_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"issue":"Suppl 4","key":"10.1016\/j.jhepr.2023.100777_bib4","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1093\/cid\/ciw092","article-title":"Hepatitis B in pregnancy","volume":"62","author":"Tran","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib6","article-title":"Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. ISBN 978-92-4-000270-8 (electronic version)","year":"2020","journal-title":"Licence: CC BY-NC-SA 3.0 IGO"},{"key":"10.1016\/j.jhepr.2023.100777_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100777_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12072-021-10285-5","article-title":"Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy","volume":"16","author":"Kumar","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2471\/BLT.20.281311","article-title":"Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique","volume":"100","author":"Loarec","year":"2022","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jhepr.2023.100777_bib11","unstructured":"Triple elimination initiative of mother-to-child transmission of HIV, syphilis and hepatitis B. https:\/\/www.who.int\/initiatives\/triple-elimination-initiative-of-mother-to-child-transmission-of-hiv-syphilis-and-hepatitis-b (accessed August 8, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib12","series-title":"Regional framework for the triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in Asia and the Pacific","year":"2018"},{"key":"10.1016\/j.jhepr.2023.100777_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ije\/dyz037","article-title":"Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and\u00a0cost-effective: an economic evaluation","volume":"48","author":"Zhang","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"Suppl 9","key":"10.1016\/j.jhepr.2023.100777_bib14","doi-asserted-by":"crossref","first-page":"J36","DOI":"10.1016\/j.vaccine.2012.11.061","article-title":"Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation","volume":"31","author":"Cui","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 9","key":"10.1016\/j.jhepr.2023.100777_bib15","doi-asserted-by":"crossref","first-page":"J15","DOI":"10.1016\/j.vaccine.2013.03.045","article-title":"The inception, achievements, and implications of the China GAVI alliance project on hepatitis B immunization","volume":"31","author":"Kane","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib16","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1038\/s41467-021-26475-6","article-title":"The impact of the timely birth dose vaccine on the global elimination of hepatitis B.","volume":"12","author":"de Villiers","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100777_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004275","article-title":"The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection","volume":"6","author":"Pley","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000848","article-title":"Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020","volume":"25","author":"McDonald","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jhepr.2023.100777_bib19","article-title":"Africa\u2019s struggle with hepatitis B","author":"Nordling","year":"2022","journal-title":"Nat Publishing Group UK"},{"key":"10.1016\/j.jhepr.2023.100777_bib20","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections","author":"Programmes","year":"2021"},{"key":"10.1016\/j.jhepr.2023.100777_bib21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/JCM.02980-14","article-title":"Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa","volume":"53","author":"Njai","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhepr.2023.100777_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","article-title":"Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention","volume":"59","author":"Wen","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2893.2010.01333.x","article-title":"Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants","volume":"18","author":"Singh","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","article-title":"Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis","volume":"21","author":"Boucheron","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib25","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/13596535221076640","article-title":"The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B","volume":"27","author":"Pan","year":"2022","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhepr.2023.100777_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib28","series-title":"U.S. food and drug administration (FDA)","year":"2022"},{"key":"10.1016\/j.jhepr.2023.100777_bib29","series-title":"WHO: Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Web Annex A: systematic review of the efficacy and safety of antiviral therapy during pregnancy","author":"Funk","year":"2020"},{"key":"10.1016\/j.jhepr.2023.100777_bib30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12072-021-10235-1","article-title":"Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load","volume":"15","author":"Li","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/COH.0000000000000379","article-title":"Candidates for inclusion in a universal antiretroviral regimen: tenofovir alafenamide","volume":"12","author":"Gotham","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jhepr.2023.100777_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/apt.17107","article-title":"Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study","volume":"56","author":"Ogawa","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100777_bib33","doi-asserted-by":"crossref","first-page":"e3324","DOI":"10.1093\/cid\/ciaa1939","article-title":"Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective, observational study","volume":"73","author":"Zeng","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/apt.16043","article-title":"Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study","volume":"52","author":"Ding","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100777_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.17040","article-title":"Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection","volume":"56","author":"Kayes","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 3","key":"10.1016\/j.jhepr.2023.100777_bib36","first-page":"25","volume":"2022","author":"Avihingsanon","year":"2022","journal-title":"n J Int AIDS Soc"},{"key":"10.1016\/j.jhepr.2023.100777_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40273-019-00852-y","article-title":"Cost-Effectiveness of tenofovir alafenamide for treatment of chronic hepatitis B in Canada","volume":"38","author":"Tian","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jhepr.2023.100777_bib38","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jhepr.2023.100777_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4102\/sajhivmed.v20i1.971","article-title":"Birth outcomes following antiretroviral exposure during pregnancy: initial results from a pregnancy exposure registry in South Africa","volume":"20","author":"Mehta","year":"2019","journal-title":"South Afr J HIV Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/QAI.0000000000000847","article-title":"Reassuring birth outcomes with tenofovir\/emtricitabine\/efavirenz used for prevention of mother-to-child transmission of HIV in Botswana","volume":"71","author":"Zash","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jhepr.2023.100777_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2016.00199","article-title":"The PHACS SMARTT study: assessment of the safety of in utero exposure to antiretroviral drugs","volume":"7","author":"Van Dyke","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100777_bib42","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/aje\/kwab109","article-title":"Safety of tenofovir disoproxil fumarate for pregnant women facing the coronavirus disease 2019 pandemic","volume":"190","author":"Hern\u00e1ndez-D\u00edaz","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhepr.2023.100777_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/ciy982","article-title":"Maternal and infant bone mineral density 1 Year after delivery in a randomized, controlled trial of maternal tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus","volume":"69","author":"Salvadori","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.01.021","article-title":"Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate","volume":"72","author":"Wen","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/gutjnl-2020-322719","article-title":"Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China","volume":"71","author":"Pan","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100777_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/jvh.13104","article-title":"Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B","volume":"26","author":"Di Bisceglie","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib47","doi-asserted-by":"crossref","first-page":"687785","DOI":"10.3389\/fmicb.2021.687785","article-title":"The genotype (A to H) dependent N-terminal sequence of HBV large surface protein affects viral replication, secretion and infectivity","volume":"12","author":"Ou","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhepr.2023.100777_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28125","article-title":"A\u00a0cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B","volume":"95","author":"Chalid","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2023.100777_bib49","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/hep4.1595","article-title":"Characteristics of patients with chronic hepatitis B virus infection with genotype E predominance in Burkina Faso","volume":"4","author":"Wongjarupong","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100777_bib50","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4254\/wjh.v13.i12.1875","article-title":"Genotype E: the neglected genotype of hepatitis B virus","volume":"13","author":"Ingasia","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib51","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0434","article-title":"Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy","author":"Inoue","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jvh.13499","article-title":"Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B","volume":"28","author":"Post","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib53","unstructured":"WHO prequalifications list 2020 (produced by World Hepatitis Alliance). chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.worldhepatitisalliance.org\/missing-millions\/wp-content\/uploads\/2020\/04\/WHO-prequalifications-list-2020.pdf n.d."},{"key":"10.1016\/j.jhepr.2023.100777_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-022-35729-w","article-title":"Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa","volume":"14","author":"Johannessen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100777_bib55","article-title":"Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors","volume":"10","author":"O\u2019Hara","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2023.100777_bib56","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00431-014-2305-7","article-title":"A\u00a0study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission","volume":"173","author":"Zhang","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhepr.2023.100777_bib57","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jmv.2187","article-title":"Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study","volume":"67","author":"Xu","year":"2002","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2023.100777_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00404-010-1366-8","article-title":"The study on role of peripheral blood mononuclear cell in HBV intrauterine infection","volume":"283","author":"Bai","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jhepr.2023.100777_bib60","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/aogs.14448","article-title":"Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: a systematic review and meta-analysis","volume":"101","author":"Yao","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jhepr.2023.100777_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1814556","article-title":"Effect of universal testing and treatment on HIV incidence - HPTN 071 (PopART)","volume":"381","author":"Hayes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1186\/s12889-019-7095-4","article-title":"Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa","volume":"19","author":"Mokaya","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib63","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12879-021-06226-0","article-title":"Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejogrb.2013.02.001","article-title":"Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy","volume":"169","author":"Cheung","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jhepr.2023.100777_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251552","article-title":"Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV","volume":"16","author":"Pan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100777_bib66","article-title":"Tenofovir-DF therapy prevents hepatitis B vertical transmission in highly viraemic mothers without HBV immunoglobulin for infants","author":"Pan","year":"2023","journal-title":"The Liver Meeting AASLD"},{"key":"10.1016\/j.jhepr.2023.100777_bib67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12072-020-10026-0","article-title":"Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jvh.13036","article-title":"Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis","volume":"26","author":"Song","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038123","article-title":"Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy","volume":"10","author":"Bierhoff","year":"2020","journal-title":"BMJ Open"},{"issue":"103","key":"10.1016\/j.jhepr.2023.100777_bib70","first-page":"337","article-title":"South African guideline for the management of chronic hepatitis B","volume":"2013","author":"Spearman","year":"2013","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.jhepr.2023.100777_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v14050900","article-title":"Early Treatment Consideration in Patients with Hepatitis B \u201ce\u201d Antigen-Positive Chronic Infection: is It Time for a Paradigm Shift?","volume":"14","author":"Koffas","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2023.100777_bib72","article-title":"Simplifying treatment criteria in chronic hepatitis B: reducing barriers to elimination","author":"Wong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41575-020-00398-x","article-title":"Extending treatment eligibility for chronic hepatitis B virus infection","volume":"18","author":"McNaughton","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.5009\/gnl21001","article-title":"Clinical and immunological factors associated with postpartum hepatic flares in immune-tolerant pregnant women with hepatitis B virus infection treated with telbivudine","volume":"15","author":"Lu","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2023.100777_bib75","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/apt.16123","article-title":"Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America","volume":"52","author":"Samadi Kochaksaraei","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100777_bib76","doi-asserted-by":"crossref","first-page":"7046955","DOI":"10.1155\/2022\/7046955","article-title":"Antiviral therapy for prevention of perinatal hepatitis B virus transmission reduces the incidence of postpartum hepatitis flare","volume":"2022","author":"Quan","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib77","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.14309\/ajg.0000000000000221","article-title":"Total alanine aminotransferase (ALT) flares in pregnant north American women with chronic hepatitis B infection: results from a prospective observational study","volume":"114","author":"Bzowej","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100777_bib78","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","article-title":"Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B","volume":"64","author":"Giles","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100777_bib79","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/liv.15249","article-title":"Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes","volume":"42","author":"Samadi Kochaksaraei","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib80","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/apt.12726","article-title":"Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare","volume":"39","author":"Nguyen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100777_bib81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jvh.13231","article-title":"Mother-to-child transmission of hepatitis B: what more needs to be done to eliminate it around the world?","volume":"27","author":"Nayagam","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib82","first-page":"121","article-title":"Treatment advantage in HBV\/HIV coinfection compared to HBV monoinfection in a South African cohort","volume":"81","author":"Maponga","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"12","key":"10.1016\/j.jhepr.2023.100777_bib83","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","article-title":"Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets","volume":"2","author":"Spearman","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1341-8076.2002.00076.x","article-title":"Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy","volume":"29","author":"Gupta","year":"2003","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jhepr.2023.100777_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003068","article-title":"Hepatitis B virus seroepidemiology data for Africa: modelling intervention strategies based on a systematic review and meta-analysis","volume":"17","author":"McNaughton","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib86","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jvh.13314","article-title":"The role of caesarean section and nonbreastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg-and HBeAg-positive mothers: results from a prospective cohort study and a meta-analysis","volume":"27","author":"Pan","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib87","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1080\/14767058.2020.1819229","article-title":"Cesarean section in reducing mother-to-child HBV transmission: a meta-analysis","volume":"35","author":"He","year":"2022","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib88","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","article-title":"Hepatitis B vaccines: WHO position paper\u2013recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib89","first-page":"405","article-title":"Hepatitis B vaccines","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jhepr.2023.100777_bib90","unstructured":"UNICEF supply division: Hepatitis B (HepB) vaccine price data n.d. https:\/\/www.unicef.org\/supply\/documents\/hepatitis-b-hepb-vaccine-price-data (accessed July 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12962-020-00219-7","article-title":"Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation","volume":"18","author":"Memirie","year":"2020","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.jhepr.2023.100777_bib92","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1016\/j.vaccine.2009.08.034","article-title":"Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination","volume":"27","author":"Tharmaphornpilas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2471\/BLT.16.178822","article-title":"Hepatitis B vaccination timing: results from demographic health surveys in 47 countries","volume":"95","author":"Schweitzer","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jhepr.2023.100777_bib94","unstructured":"Kaufman J. A defining moment for medicines regulation in Africa: the establishment of the African Medicines Agency. Cent Glob Develop Ideas Action. https:\/\/www.cgdev.org\/blog\/defining-moment-medicines-regulation-africa-establishment-african-medicines-agency (accessed July 14, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jvh.13719","article-title":"Progress towards the elimination of hepatitis B in children in Colombia: a novel two-phase study approach","volume":"29","author":"R\u00edos-Hincapi\u00e9","year":"2022","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib96","unstructured":"Country data dashboards n.d. https:\/\/www.globalhep.org\/country-data-dashboards (accessed August 9, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib97","unstructured":"UNICEF Data Warehouse n.d. https:\/\/data.unicef.org\/resources\/data_explorer\/unicef_f\/?ag=UNICEF&df=GLOBAL_DATAFLOW&ver=1.0&dq=.IM_HEPBB..&startPeriod=2015&endPeriod=2018 (accessed August 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib98","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12889-017-4227-6","article-title":"Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas","volume":"17","author":"Ropero \u00c1lvarez","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib99","article-title":"Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development","volume":"0","author":"Njuguna","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib100","doi-asserted-by":"crossref","first-page":"e3317","DOI":"10.1093\/cid\/ciaa898","article-title":"Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus","volume":"73","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib101","series-title":"Hepatitis B vaccines: Conclusions and Proposed Recommendations for SAGE","author":"Johansen","year":"2016"},{"key":"10.1016\/j.jhepr.2023.100777_bib102","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/S2214-109X(18)30219-5","article-title":"Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study","volume":"6","author":"Scott","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib103","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2016.10.091","article-title":"Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines","volume":"35","author":"Kahn","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib104","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-21-00277","article-title":"Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-saharan Africa","volume":"10","author":"Boisson","year":"2022","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.jhepr.2023.100777_bib105","series-title":"Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination","article-title":"Expanded programme on immunization (EPI) of the department of immunization, vaccines and biologicals","year":"2015"},{"key":"10.1016\/j.jhepr.2023.100777_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/v14010082","article-title":"Global disparities in hepatitis B elimination-A focus on Africa","volume":"14","author":"Sonderup","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2023.100777_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12916-019-1269-x","article-title":"HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model","volume":"17","author":"McNaughton","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jhepr.2023.100777_bib108","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jvh.13525","article-title":"Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations","volume":"28","author":"Mokaya","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2023.100777_bib109","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2214-109X(22)00026-2","article-title":"Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study","volume":"10","author":"Shimakawa","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib110","unstructured":"Neal J, Mandal S. WHO highlights role of screening and vaccination in reaching hepatitis B control targets n.d. https:\/\/phescreening.blog.gov.uk\/2021\/09\/29\/who-highlights-role-of-screening-and-vaccination-in-reaching-hepatitis-b-control-targets\/(accessed November 7, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib111","unstructured":"WHO Report: Criteria for validation of elimination of viral hepatitis B and C: report of 7 country pilots 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240055292 (accessed November 7, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib112","doi-asserted-by":"crossref","first-page":"958","DOI":"10.15585\/mmwr.mm7130a2","article-title":"Progress toward the elimination of mother-to-child transmission of hepatitis B virus - worldwide, 2016-2021","volume":"71","author":"Khetsuriani","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jhepr.2023.100777_bib113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1358\/dot.2007.43.6.1050792","article-title":"Hepatitis B immune globulin","volume":"43","author":"Habib","year":"2007","journal-title":"Drugs Today"},{"key":"10.1016\/j.jhepr.2023.100777_bib114","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jmv.20816","article-title":"Review: hepatitis B immune globulin for prevention of hepatitis B infection","volume":"79","author":"Zuckerman","year":"2007","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2023.100777_bib115","unstructured":"Recommendation of the Immunization Practices Advisory Committee (ACIP) Postexposure Prophylaxis of Hepatitis B 1984. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00022736.htm (accessed June 25, 2022)."},{"issue":"RR16","key":"10.1016\/j.jhepr.2023.100777_bib116","first-page":"27","article-title":"Immunization management issues","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.jhepr.2023.100777_bib117","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.vaccine.2015.01.054","article-title":"Prevention of perinatal hepatitis B transmission in Haimen City, China: results of a community public health initiative","volume":"33","author":"Evans","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib118","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.jhepr.2023.100777_bib119","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","article-title":"Prevention of the hbsag carrier state in newborn infants of mothers who are chronic carriers of hbsag and hbeag by administration of hepatitis-b vaccine and hepatitis-b immunoglobulin","volume":"323","author":"Wong","year":"1984","journal-title":"The Lancet"},{"key":"10.1016\/j.jhepr.2023.100777_bib120","doi-asserted-by":"crossref","first-page":"11759","DOI":"10.1038\/s41598-022-15744-z","article-title":"The effectiveness of 20 \u03bcg hepatitis B vaccine used for the prevention of HBV vertical transmission","volume":"12","author":"Yonghao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100777_bib121","first-page":"285","article-title":"Postexposure prophylaxis of hepatitis B.","volume":"33","year":"1984","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jhepr.2023.100777_bib122","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1542\/peds.2012-1262","article-title":"Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment","volume":"131","author":"Chen","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhepr.2023.100777_bib123","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.vaccine.2021.04.041","article-title":"Prevention of hepatitis B mother-to-child transmission in Namibia: a cost-effectiveness analysis","volume":"39","author":"Tamandjou Tchuem","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib124","unstructured":"UKHSA. Immunisation against infectious disease (the \u201cGreen Book\u201d), Chapter 18: Hepatitis B (updated 4 Feb 2022), Edited by Dr Mary Ramsay n.d."},{"key":"10.1016\/j.jhepr.2023.100777_bib125","doi-asserted-by":"crossref","first-page":"4747965","DOI":"10.1155\/2020\/4747965","article-title":"Hepatitis B infection and mother-to-child transmission in haiphong, vietnam: a cohort study with implications for interventions","volume":"2020","author":"Khue","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2023.100777_bib126","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","article-title":"Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV","volume":"142","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100777_bib127","doi-asserted-by":"crossref","first-page":"566","DOI":"10.11622\/smedj.2015194","article-title":"Limited benefit of hepatitis B immunoglobulin prophylaxis in children of hepatitis B e antigen-negative mothers","volume":"57","author":"Lee","year":"2016","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jhepr.2023.100777_bib128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1473-3099(22)00206-7","article-title":"Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial","volume":"22","author":"Segeral","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jac\/dku404","article-title":"Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+\/HBeAg- mothers: a systematic review and meta-analysis","volume":"70","author":"Machaira","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhepr.2023.100777_bib130","unstructured":"Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03476083 (accessed December 13, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib131","unstructured":"Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf. Accessed on 12-Aug-2022 n.d."},{"key":"10.1016\/j.jhepr.2023.100777_bib132","unstructured":"Reducing Vertical Transmission of Hepatitis B in Africa - Full Text View - ClinicalTrials.Gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04704024 (accessed August 9, 2022)."},{"key":"10.1016\/j.jhepr.2023.100777_bib133","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058722","article-title":"Integrating hepatitis B care and treatment with existing HIV services is possible: cost of integrated HIV and hepatitis B treatment in a low-resource setting: a cross-sectional hospital-based cost-minimisation assessment","volume":"12","author":"Ejalu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2023.100777_bib134","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0956462420953722","article-title":"Feasibility, benefits, and cost-effectiveness of adding universal hepatitis B and syphilis testing to routine antenatal care services in Thai Nguyen province","volume":"32","author":"Nguyen","year":"2021","journal-title":"Vietnam Int J STD AIDS"},{"key":"10.1016\/j.jhepr.2023.100777_bib135","article-title":"Hepatitis B vaccination in Senegalese children: coverage, timeliness, and sociodemographic determinants of non-adherence to immunisation schedules (ANRS 12356 AmBASS survey)","volume":"9","author":"P\u00e9ri\u00e8res","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jhepr.2023.100777_bib136","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1016\/j.vaccine.2020.11.009","article-title":"Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam","volume":"38","author":"Thanh Thi Le","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib137","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.vaccine.2017.11.004","article-title":"Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence","volume":"36","author":"Garcia","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2023.100777_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005842","article-title":"Hepatitis B virus infection as a neglected tropical disease","volume":"11","author":"O\u2019Hara","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jhepr.2023.100777_bib139","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2468-1253(21)00475-1","article-title":"A\u00a0call for advocacy and patient voice to eliminate hepatitis B virus infection","volume":"7","author":"Matthews","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.12688\/wellcomeopenres.14273.1","article-title":"A\u00a0blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - a systematic review","volume":"3","author":"Mokaya","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jhepr.2023.100777_bib141","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fpubh.2019.00304","article-title":"A\u00a0study of knowledge, experience, and beliefs about hepatitis B virus (HBV) infection in South western Uganda","volume":"7","author":"Mugisha","year":"2019","journal-title":"Front Public Health"},{"issue":"Suppl","key":"10.1016\/j.jhepr.2023.100777_bib142","first-page":"31","article-title":"Implementing a birth dose of hepatitis B vaccine in Africa: findings from assessments in 5 countries","author":"Moturi","year":"2018","journal-title":"J\u00a0Immunol Sci"},{"key":"10.1016\/j.jhepr.2023.100777_bib143","article-title":"Coverage with timely administered vaccination against hepatitis B virus and its influence on the prevalence of HBV infection in the regions of different endemicity","volume":"9","author":"Kyuregyan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jhepr.2023.100777_bib144","series-title":"Abstract presented at conference on liver disease in Africa 2021. Reviews in antiviral therapy and infectious disease","first-page":"6","article-title":"Ben bashir H, saidu Y, prescott M. Key considerations for the introduction of hepatitis B birth dose vaccine in Cameroon","author":"Kamga","year":"2021"},{"key":"10.1016\/j.jhepr.2023.100777_bib145","doi-asserted-by":"crossref","first-page":"e1600","DOI":"10.1016\/S2214-109X(21)00304-1","article-title":"Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study","volume":"9","author":"Thompson","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2023.100777_bib146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12884-021-03914-2","article-title":"A\u00a0mixed-methods evaluation of hepatitis B knowledge, attitudes, and practices among migrant women in Thailand","volume":"21","author":"Bierhoff","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"RR08","key":"10.1016\/j.jhepr.2023.100777_bib147","first-page":"1","article-title":"CDC Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"RR-16","key":"10.1016\/j.jhepr.2023.100777_bib148","first-page":"1","article-title":"Bell. Hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jhepr.2023.100777_bib149","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100777_bib150","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0847-2","article-title":"Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries","volume":"18","author":"Li","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100777_bib151","first-page":"66","article-title":"Lamivudine\u2019s efficacy and safety in preventing mother-to-child transmission of hepatitis B: a meta-analysis","volume":"30","author":"Khalighinejad","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100777_bib152","first-page":"197","article-title":"Comparing the efficacy and safety of treating chronic hepatitis B infection during pregnancy with lamivudine, telbivudine, and tenofovir: a meta-analysis","volume":"7","author":"Sali","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2023.100777_bib153","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12884-017-1487-1","article-title":"Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: a meta-analysis","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jhepr.2023.100777_bib154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.midw.2019.03.024","article-title":"Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: a systematic review and a meta-analysis","volume":"74","author":"Chen","year":"2019","journal-title":"Midwifery"},{"key":"10.1016\/j.jhepr.2023.100777_bib155","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/INF.0000000000000315","article-title":"Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population: a hospital-based study and a meta-analysis","volume":"33","author":"Lin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhepr.2023.100777_bib156","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12887-014-0307-2","article-title":"Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials","volume":"14","author":"Jin","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jhepr.2023.100777_bib157","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus","volume":"2","author":"Eke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2023.100777_bib158","article-title":"Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: a systematic review and meta-analysis","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.jhepr.2023.100777_bib159","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10620-013-2918-0","article-title":"Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis","volume":"59","author":"Xu","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100777_bib160","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx225","article-title":"Comparative effectiveness of prophylactic strategies for perinatal transmission of hepatitis B virus: a network meta-analysis of randomized controlled trials","volume":"4","author":"Chen","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:51Z","timestamp":1762900431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":160,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2589555923001088"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100777","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100777"}}